Listen Now
Topics Covered
- Overview of Non-Hodgkin Lymphoma (NHL)
- Signs & Symptoms, in the Context of COVID-19
- NHL Staging & Subtypes
- Indolent & Aggressive
- Relapsed & Refractory NHL
- Novel Treatment Approaches
- The Role of Clinical Trials
- How Research Adds to Your Treatment Options
- Your Comfort Level with Adherence
- Managing Treatment Side Effects, in the Context of COVID-19
- Communicating with Your Health Care Team about Quality-of-Life Concerns
- Follow-Up Care Appointments
- The Increasing Role of Telehealth & Telemedicine Appointments
- Guidelines to Prepare for Telehealth/ Telemedicine Appointments, including Technology & List of Questions
- Questions for Our Panel of Experts
Our Panel of Experts

Ajay K. Gopal, MD
Professor of Medicine, Division of Medical Oncology, University of Washington, Member, Clinical Research Division, Fred Hutchinson Cancer Research Center, Clinical Research Director and Associate Medical Director, Hematology and Hematologic Malignancies, Seattle Cancer Care Alliance

Andrew M. Evens, DO, MSc, FACP
Professor of Medicine, Rutgers Robert Wood Johnson Medical School, Associate Director for Clinical Services, Rutgers Cancer Institute of New Jersey, Director, Lymphoma Program, Division of Blood Disorders, Medical Director, Oncology Service Line, RWJBarnabas Health

Thomas M. Habermann, MD
Professor of Medicine, Mayo Clinic College of Medicine

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on May 20, 2021.